Description
Perspectives on the Adoption and Implementation
Perspectives on the Adoption and Implementation of Continuous ManufacturingThis session will include 3 highly regarded experts in the CM for biological molecules. These experts will share perspectives and experiences on the development and potential adoption of CM for large molecules.
- Integrated Approach to Semi-Continuous Drug Substance Manufacturing
Mehdi Ghodbane, PhD, Downstream Process Development, Medicinal Science & Technology
GlaxoSmithKline
- N-1 Perfusion from Development through GMP Implementation
Gene Schaefer, Senior Director Large Molecule API Development
Janssen
- Sanofi’s MA Digitalized Facility, an Ecosystem of the Future
Navin Tiwari, Director, Head of Digital Shop Floor & Automation
Sanofi
Moderator(s):
- Kelvin
Lee,
PhD,
Director and Professor, Chemical & Biomolecular Engineering, Univ. of Delaware,
NIMBL
Speaker(s):
